The team of our chief scientific advisor has succeeded in inducing the first differentiation of pluripotent stem cells that produce EPO.
They also showed that the cell transplantation is effective in treating renal anemia in a mouse model. It is expected as a new therapy for renal anemia that enables physiological control.
A patent has been obtained for the method of inducing erythropoietin-producing cells.
A patent has been obtained for the method of inducing producing cells.
(Hitomi H, et al., Science Translational Medicine 2017; 特許第6112733号, US Patent No.9,334,475, EP Patent No.2837681)